Pharmacotheraphy for Alzheimer's disease.

被引：19
作者：
Knopman D. [1 ]
机构：
[1] Department of Neurology, Mayo Clinic, 200 First Street Southwest, Rochester, 55905, MN
来源：
Current Neurology and Neuroscience Reports | 2001年 / 1卷 / 5期
关键词：
Mild Cognitive Impairment; Memantine; Dementia With Lewy Body; Rivastigmine; Tacrine;
D O I：
10.1007/s11910-001-0102-y
中图分类号：
学科分类号：
摘要：
In the past 2 years, substantive advances in therapy for Alzheimer's disease (AD) have occurred. The nature of the effects of cholinesterase inhibitors has been refined with the publication of several studies that have examined different aspects of the symptomatology of AD. Breakthroughs in the basic science of Alzheimer's disease have led to new insights into potential therapeutic strategies targeted at the secretases involved in the metabolism of the Alzheimer precursor protein. An immunization approach, in which the beta-amyloid protein itself was used as the immunizing agent, has also been presented and independently validated. Other areas of investigation with disappointing results, such as estrogen replacement therapy, anti-inflammatory approaches, and several other therapeutic agents, are also reviewed.
引用
收藏
页码：428 / 434
页数：6
相关论文
共 181 条
[31]  
Rossor M(1999)Two transmembrane aspartates in presenilin-1 required for presenilin endoproteolysis and gamma-secretase activity Nature 398 513-517
[32]  
Hecker J(1998)Presenilin 1 regulates the processing of beta-amyloid precursor protein C-terminal fragments and the generation of amyloid beta-protein in endoplasmic reticulum and Golgi Biochemistry 37 16465-16471
[33]  
Rosler M(2000)Presenilin 1 is linked with gammasecretase activity in the detergent solubilized state Proc Natl Acad Sci U S A 97 6138-6143
[34]  
Anand R(1996)Increased amyloidbeta 42 (43) in brains of mice expressing mutant presenilin 1 Nature 383 710-713
[35]  
Cicin-Sain A(1999)beta-secretase cleavage of Alzheimer’s amyloid precursor protein by the transmembrane aspartic protease BACE Science 286 735-741
[36]  
Raskind MA(1999)Membrane-anchored aspartyl protease with Alzheimer’s disease beta-secretase activity Nature 402 533-537
[37]  
Peskind ER(1999)Purification and cloning of amyloid precursor protein beta-secretase from human brain Nature 402 537-540
[38]  
Wessel T(1999)Identification of a novel aspartic protease (Asp 2) as beta-secretase Mol Cell Neurosci 14 419-427
[39]  
Tariot PN(1999)Immunization with amyloid-beta attenuates Alzheimer-disease-like pathology in the PDAPP mouse Nature 400 173-177
[40]  
Solomon PR(1995)Alzheimer-type neuropathology in transgenic mice overexpressing V717F beta-amyloid precursor protein Nature 373 523-527
12345678910